What are the main differences of SSRI's versus Prescription Ketamine for depression, Anxiety and Mood Disorder

Here’s the challenge: studies on both treatments show a wide range of results, making direct comparisons difficult. To cut through the noise, I’ve drawn from systematic reviews and meta-analyses—the most reliable forms of evidence—and focused on the midpoints across studies. The goal is to give you a clear, realistic comparison without oversimplifying how complex these treatments truly are.

Before diving in, let’s clarify the variables.

• SSRIs vary based on three main factors: how long a person stays on the medication, which specific drug they take, and how treatment response is measured (since psychiatrists use different scales).

• Ketamine therapy depends on the route of administration (IV infusion, intramuscular injection, nasal spray, or oral dosing), dosage, and whether maintenance sessions are continued after the initial series.

With that in mind, here are eight key differences between ketamine therapy and SSRIs—summarized from over 30 systematic reviews and meta-analyses published in leading scholarly archives.

1. How Treatment Is Delivered

SSRIs

A daily oral medication taken at home—usually once or twice a day at the same time.

Ketamine Therapy

A medically supervised procedure performed in a clinic. Treatments are delivered via IV infusion, injection, or nasal spray. Each session typically lasts around two hours from start to finish.

 

2. Mechanism of Action

How each treatment works in the brain

SSRIs

SSRIs increase serotonin levels by preventing neurons from reabsorbing it after it’s released into the synaptic cleft. With more serotonin available, brain cells can communicate more effectively—gradually improving mood over several weeks.

Ketamine Therapy

Ketamine works on a different system entirely. By blocking NMDA receptors, it triggers a surge of glutamate—activating pathways that produce proteins like BDNF and mTOR. These help rebuild and strengthen neural connections damaged by depression. In short, ketamine doesn’t just adjust brain chemistry; it promotes actual repair and regeneration in mood-related circuits.

3. Treatment Experience

What it feels like

SSRIs

No immediate effects. It’s like taking a vitamin—you swallow it and continue your day.

Ketamine Therapy

Profound, fast-acting effects. Many people experience a dreamlike or dissociative state—feeling detached from the body or perception of time. Some describe floating sensations, visual distortions, or a deep sense of calm. For others, it’s an emotionally clarifying or meditative experience that can bring relief within hours.

 

4. Duration of Treatment

How long treatment typically lasts

SSRIs

Usually prescribed for 6–12 months or longer. Some people remain on them for years.

Ketamine Therapy

Typically involves 10–14 initial sessions (for IV or IM treatments), followed by “booster” sessions spaced from monthly to annually—depending on response and maintenance needs. Esketamine (Spravato) protocols are similar, requiring at least 14 sessions before tapering.

 

5. Side Effects

Unwanted effects that can accompany treatment

SSRIs

Weight gain, sexual dysfunction, emotional numbness, fatigue, and digestive changes are common. While many side effects improve over time, some can persist for months or years.

Ketamine Therapy

Short-lived dissociation, dizziness, mild nausea, and drowsiness may occur during or shortly after treatment. These typically resolve within a few hours.

 

6. Speed of Action

How quickly noticeable relief occurs

SSRIs

Relief usually appears within 4–6 weeks.

Ketamine Therapy

Improvement can begin within hours to days—often after the very first session.

 

7. Response Rates

A 50% reduction in depressive symptoms from baseline

SSRIs

Roughly 45% of people experience a 50% or greater improvement in symptoms.

Ketamine Therapy

About 55% of patients reach the same threshold—often after failing multiple prior treatments.

8. Remission Rates

When symptoms are nearly or completely gone

SSRIs

Approximately 35% of patients achieve remission.

Ketamine Therapy

Up to 70% reach remission—even in treatment-resistant depression, the hardest form to treat.

It’s important to note that ketamine’s numbers are drawn from populations who have already failed multiple antidepressants. If it can double remission rates in the toughest cases, imagine what might happen if it were tested on mild to moderate depression—the population typically used in SSRI trials. In other words, ketamine isn’t just outperforming SSRIs; it’s doing so under the most difficult conditions.

 

Want to get more info about Ketamine vs. SSRI's? Companies like BlissMistRx.com offer free 20 minute telehealth appointments with licensed doctors.